MedTrace Logo

Probiotics and Recovery From Gastrointestinal Surgery - 2

NCT04266106 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2020-02-13

No results posted yet for this study

Summary

This prospective randomized trial is designed to test a pragmatic simple intervention in a community hospital. The trial will test the hypothesis whether patient recovery after a major elective abdominal operation can be improved and/or accelerated with postoperative use of probiotics.

Conditions

  • Surgical Recovery

Interventions

DRUG

SuperBio probiotic

One capsule po BID for 28 days

DRUG

Placebo

One capsule po BID for 28 days

Sponsors & Collaborators

  • SuperBio

    collaborator UNKNOWN

  • Jan Franko, MD

    lead OTHER

Principal Investigators

  • Jan Franko · MercyOne Des Moines Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-29
Primary Completion
2021-06-30
Completion
2021-10-31
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04266106 on ClinicalTrials.gov